Nature
COVID-19 long-acting antibodies discovered by Vanderbilt University Medical Center move to phase 3 clinical trials
Oct. 13, 2020—AstraZeneca is advancing into phase 3 clinical trials with an investigational COVID-19 therapy of two long-acting antibodies discovered by Vanderbilt University Medical Center and optimized by AstraZeneca.
Vanderbilt astronomers among NASA’s TESS Mission team to discover a rare newly formed planet
Jun. 24, 2020—Stars mapped out by Vanderbilt astronomers for exploration by NASA’s Transiting Exoplanet Survey Satellite mission and recently decommissioned Spitzer Space Telescope have led to the discovery of AU Mic b, a newly formed Neptune-like exoplanet located a relatively short 31.9 light-years away.
Study identifies critical regulator of tumor-specific T cell differentiation
Jun. 18, 2019—A study published June 17 in Nature offers clues as to why blocking inhibitory receptors on tumor-infiltrating T cells may not always work
VU’s high-quality natural sciences research output rises according to 2018 Nature Index
Jun. 7, 2018—The Nature Index tracks author affiliation information from articles published in 68 prestigious natural science journals and ranks institutions according to their rate of inclusion in those journals.
Alphavirus “Achilles heel”
May. 17, 2018—Targeting the protein that mosquito-borne viruses use to enter cells could be a strategy for preventing infection by multiple emerging viruses.
Study catches ‘notorious’ drug pump in action
Mar. 16, 2017—Researchers at Vanderbilt University Medical Center (VUMC) have mapped the conformational changes that occur in a protein “notorious” for pumping chemotherapeutic drugs out of cancer cells and blocking medications from reaching the central nervous system.
Early study finds antibody that ‘neutralizes’ Zika virus
Nov. 7, 2016—Researchers at Vanderbilt University Medical Center and Washington University School of Medicine in St. Louis have isolated a human monoclonal antibody that in a mouse model “markedly reduced” infection by the Zika virus.
Study explores low oxygen’s impact on antibody quality
Aug. 11, 2016—Hypoxia (lack of enough oxygen) is bad for the body as a whole, but in the neighborhood where infection-fighting antibodies arise, may be important for keeping proper order.
Philosophers honor Lenn Goodman’s research in new book
Apr. 15, 2015—Lenn Goodman, whose philosophical research is being lauded in a book that includes his name in the title, will be honored by academic colleagues at an April 20 public celebration in Buttrick Hall.
New signaling pathway provides clues to obesity
Jan. 22, 2015—A Vanderbilt University-led research team has discovered a molecular “rheostat” in the brain’s appetite control center that may provide new insights into obesity, which is at epidemic levels in this country.
Treatment Helps Frogs Fight Fungal Pathogen
Sep. 26, 2014—Simple heat treatments may give the frog immune system a boost and help it fight off a deadly fungal pathogen, according to a new study published July 10 in the journal Nature.
Colon cancer’s protein signatures identified
Jul. 24, 2014—A Vanderbilt University-led research team has identified protein “signatures” of genetic mutations that drive colorectal cancer, the nation’s second leading cause of cancer deaths after lung cancer.